Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 20, 2019 Off

Camurs gets FDA’s green light to kick off phase 3 testing of treatment of acromegaly and neuroendocrine tumors

By Dino Mustafić

Camurus will start with the Phase 3 study of once-monthly octreotide subcutaneous depot for treatment of acromegaly CAM2029.

Horizon Therapeutics evaluates Krystexxa in combination with methotrexate to increase response rates and duration of therapy
June 20, 2019 Off

Horizon Therapeutics evaluates Krystexxa in combination with methotrexate to increase response rates and duration of therapy

By BusinessWire

Horizon Therapeutics plc (Nasdaq: HZNP) today announced the initiation of a clinical trial evaluating KRYSTEXXA® (pegloticase injection) in combination with methotrexate as a strategy to increase the durability of response for patients living with chronic gout refractory to conventional therapies – also known as uncontrolled gout.

June 20, 2019 Off

Immunomic Therapeutics Announces Promotion of Teri Heiland, Ph.D. to Chief Scientific Officer

By BusinessWire

ROCKVILLE, Md.–(BUSINESS WIRE)–#allergies–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today the promotion of Teri Heiland, Ph.D.…

June 20, 2019 Off

CORRECTING and REPLACING Kowa Pharmaceuticals America, Inc. Receives Pediatric Indication and Six-Month Pediatric Exclusivity for LIVALO® (pitavastatin)

By BusinessWire

MONTGOMERY, Ala.–(BUSINESS WIRE)–Remove the three paragraphs with headings INDICATIONS AND USAGE, PRIMARY HYPERLIPIDEMIA AND MIXED DYSLIPIDEMIA, and LIMITATIONS OF USE…

June 20, 2019 Off

Columbia Care Announces Launch of Pioneering Research Study to Identify Genetic Factors Affecting the Efficacy and Safety of Medical Cannabis

By BusinessWire

First-of-their-kind results to enhance patient experience and efficacy of Columbia Care products by further informing and personalizing treatment recommendations to…

June 20, 2019 Off

Global Optogenetics Market Growth, Trends, and Forecasts (2019-2024) – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Optogenetics Market Growth, Trends, and Forecasts (2019-2024)” report has been added to ResearchAndMarkets.com’s offering. The major factors…

June 20, 2019 Off

2018 Market Spotlight: Benign Prostatic Hyperplasia (BPH) – GlaxoSmithKline Leads Industry Sponsors with the Highest Number of Overall Clinical Trials for BPH, Followed by Astellas & Sanofi – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Benign Prostatic Hyperplasia (BPH)” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers…

June 20, 2019 Off

Onxeo Expands its Pipeline with New Optimized Lead OX401 Entering Proof-of-Concept Preclinical Phase

By BusinessWire

OX401 is the second candidate utilizing Onxeo’s proprietary platform of decoy agonists, platON™ OX401 is optimized to be a next-generation…

June 20, 2019 Off

Global Sarcoma Market Spotlight 2018-2027: Merck & Co Leads Industry Sponsors with the Highest Number of Overall Clinical Trials for Sarcoma, Followed by Novartis & Pfizer – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Market Spotlight: Sarcoma” report has been added to ResearchAndMarkets.com’s offering. This Market Spotlight report covers the Sarcoma market,…

June 20, 2019 Off

Global Regenerative Medicine (RM) Market Report 2019: RM Industry Saw Venture Capital Investment Expand From $200 Million in 2010 to $14.6 Billion in 2018 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Market for Regenerative Medicine (RM), 2019” report has been added to ResearchAndMarkets.com’s offering. The Regenerative Medicine (RM)…

Posts pagination

Previous 1 … 3,059 3,060 3,061 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine